Cargando…
Novel Treatment Approaches in Relapsed/Refractory Mantle Cell Lymphoma: Highlights From SOHO 2021
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824285/ https://www.ncbi.nlm.nih.gov/pubmed/35186409 http://dx.doi.org/10.6004/jadpro.2022.13.1.18 |
Ejemplares similares
-
Integrating Novel Agents in Relapsed or Refractory Hodgkin Lymphoma: Highlights From SOHO 2020
Publicado: (2021) -
Immunotherapy Approaches in T-Cell Lymphoma: Highlights From SOHO 2021
Publicado: (2022) -
BCMA-Directed CAR T Cells in Relapsed Refractory Multiple Myeloma: Highlights From SOHO 2021
Publicado: (2022) -
Managing Relapsed Disease in Peripheral T-Cell Lymphoma: Highlights From SOHO 2020
Publicado: (2021) -
The Next Wave of Novel Agents in Aggressive B-Cell Lymphoma: Highlights From SOHO 2021
Publicado: (2022)